CANL
Headquartered in Denver, Colorado, CannLabs, Inc. is a leading provider of cannabis testing laboratory services throughout the United States. The company offers an extensive suite of analytical tests, including assessments for potency, residual solvents, microbiological contaminants, pesticides, heavy metals, nutrients, and terpenes. They also conduct shelf-life and stability studies, alongside gene expression and genetic profiling (genotyping/phenotyping). In addition to their laboratory work, CannLabs provides data and analytics solutions, consulting expertise, and educational services.
| Period | EPS | Revenue | FCF |
|---|---|---|---|
| 2022 Q4 | 0.00 | $1M | $337,504 |
| 2022 Q3 | 0.00 | $1M | $306,187 |
| 2022 Q2 | 0.00 | $1M | $62,306 |
| 2022 Q1 | 0.00 | $1M | $66,611 |
| 2021 Q4 | 0.00 | $565,732 | $13,135 |
| 2021 Q3 | 0.00 | $1M | $216,872 |
| 2021 Q2 | 0.00 | $814,511 | $72,791 |
| 2021 Q1 | 0.00 | $785,141 | $230,591 |